Asthma among hospitalized patients with COVID-19 and related outcomes

By Lovinsky-Desir S, Deshpande DR, De A, et al
Published August 23, 2020

Key Takeaways

In view of the high prevalence of asthma in the New York City area, researchers investigated if underlying asthma was related to poor results in hospitalized patients with severe coronavirus disease 2019 (COVID-19) vs those without asthma. This study involved 1,298 confirmed cases of severe acute respiratory syndrome coronavirus 2, with age 65 years or younger and without chronic obstructive pulmonary disease. For these patients, electronic heath records were studied. In all hospitalized patients with COVID-19, an overall prevalence of 12.6% was reported for asthma. In the subset of 55 patients younger than 21 years, a higher prevalence (23.6%) was noted. Findings demonstrated no link between asthma diagnosis and worse outcomes, irrespective of age, obesity, or other high-risk comorbidities, among hospitalized patients 65 years or younger with severe COVID-19.

Read the full article on The Journal of Allergy and Clinical Immunology.

Share with emailShare to FacebookShare to LinkedInShare to Twitter